Harjinder Kang retired after a career of almost 30 years with AstraZeneca, formerly known as ICI and Zeneca, and one of the world's leading pharmaceutical companies. Prior to his retirement Harjinder served as a Global Commercial Director based at the global HQ in London with a remit to create and implement the organisation's strategy for access to medicines for the 'next billion' people through creating affordable solutions for pharmaceuticals in some of the less developed parts of the world. Harjinder graduated as a Chemist and spent his early career in R&D helping to develop radiopharmaceuticals and new antibiotics.
Harjinder joined the UK Civil Service in 2019 where he was appointed the Director for Healthcare, Life Sciences and BioEconomy at the Department for International Trade. In 2021 he was subsequently appointed as the UK’s Chief Negotiator for the UK-India Free Trade Agreement (FTA) and led the negotiations with the Government of India. In May 2023 he was appointed as His Majesty’s Trade Commissioner to South Asia and the British Deputy High Commissioner to Western India representing the UK in this part of the world.
Harjinder is married with three daughters with one graduating in Medicine from the University of Birmingham.